Signal active
Organization
Contact Information
Overview
Redx Pharma is a drug discovery and development company formed in 2010. It is focused on improving the characteristics of existing drug classes to create best-in-class new drugs in the areas of cancer, infection and autoimmune disease. The company's work has been endorsed by partnerships with global pharmaceutical companies and the NHS.
Redx Pharma has three subsidiaries: Redx Oncology Ltd launched in April 2012, Redx Anti-Infectives Ltd launched in April 2013 and Redx Immunology Ltd launched in May 2015.
About
Biotechnology, Health Care, Pharmaceutical, Medical
2010
51-100
Headquarters locations
Europe
Social
N/A
Profile Resume
Redx Pharma headquartered in Europe, operates in the Biotechnology, Health Care, Pharmaceutical, Medical sector. The company focuses on Biotechnology and has secured $13.2B in funding across 128 round(s). With a team of 51-100 employees, Redx Pharma is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - Redx Pharma, raised $1.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
8
1
0
$103.1M
Details
0
Redx Pharma has raised a total of $103.1M in funding over 0 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|
Investors
Redx Pharma is funded by 12 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
Redx Pharma | - | FUNDING ROUND - Redx Pharma | undefined |
Acceleris Capital | - | FUNDING ROUND - Acceleris Capital | undefined |
Redx Pharma | - | FUNDING ROUND - Redx Pharma | 1.0M |
CARB-X | - | FUNDING ROUND - CARB-X | 1.0M |
Recent Activity
There is no recent news or activity for this profile.